Persistence of Positive RT-PCR for SARS-CoV-2 in an Early Allogenic Stem Cells Transplantation Recipient: A Case Study

Author Info

Hernandez T. Andres Felipe Castaño Q. Santiago Celin V. Daniel Eduardo Jaramillo E. Francisco Javier

Corresponding Author

Jaramillo E. Francisco Javier
Department of Hematology and Bone Marrow Transplantation, Hospital Universitario Fundacion Valle del Lili, Santiago de Cali, Colombia

A B S T R A C T

The new coronavirus SARS-CoV-2 has rapidly spread over the world causing the disease by WHO called COVID-19, is the defining global health crisis of our time and the greatest threat we have faced during this century [1]. According to the World Health Organizations (WHO) data, in February 2021, almost one hundred fifteen million of the population has been infected with more than two million deaths [2]. To date, in the absence of any specific treatment, our knowledge about this disease remains very limited and is subject to rapid change. This virus represents a serious danger for patients with hematologic malignancies due to myeloablative conditioning and immunosuppressive treatments. People receiving chemotherapy with compromised immune systems and complications after stem cell transplant have an increased risk for infection [3]. COVID-19 infection may complicate clinical symptoms with higher risk of respiratory distress [4]. Actually, the experience in the management of COVID-19 infection in the stem cell transplant recipients is limited.

Article Info

Article Type

Research Article

Publication history

Received: Sat 06, Mar 2021
Accepted: Tue 16, Mar 2021
Published: Fri 02, Apr 2021

Copyright

© 2023 Jaramillo E. Francisco Javier. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Hosting by Science Repository.
DOI: 10.31487/j.TCR.2021.01.02